Search for: "Mylan Pharmaceuticals, Inc." Results 21 - 40 of 497
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Oct 2022, 8:27 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 21-1567 [read post]
1 Oct 2022, 2:31 pm by Lawrence B. Ebert
The outcome: Mylan Pharmaceuticals Inc. [read post]
29 Sep 2022, 1:15 pm by Eileen McDermott
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
29 Sep 2022, 1:15 pm by Eileen McDermott
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
15 Aug 2022, 3:10 am by Moll Law Group
Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units/mL, 3 mL. [read post]
1 Jul 2022, 10:02 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 21-1567, also focuses on the written description requirement – asking what level of disclosure is necessary for a claim limitation requiring a therapeutic treatment to be “effective. [read post]
1 Feb 2022, 1:22 pm by Dennis Crouch
Mylan Pharmaceuticals Inc., Docket No. 21-01729 (Fed. [read post]
4 Jan 2022, 6:00 am by Douglas J. Bucklin, Ph.D.
Cir. 2021) 2021-1729 AstraZeneca AB and AstracZeneca Pharmacueticals LP (AstraZeneca) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
9 Dec 2021, 7:15 am by Logan Murr
On December 8, the United States Court of Appeals for the Federal Circuit (CAFC), in a precedential decision authored by Judge Stoll, vacated a  judgment of infringement against Mylan Pharmaceuticals Inc. and affirmed the nonobvious determination of the United States District Court for the Northern District of West Virginia. [read post]
9 Dec 2021, 7:15 am by Logan Murr
On December 8, the United States Court of Appeals for the Federal Circuit (CAFC), in a precedential decision authored by Judge Stoll, vacated a  judgment of infringement against Mylan Pharmaceuticals Inc. and affirmed the nonobvious determination of the United States District Court for the Northern District of West Virginia. [read post]
8 Dec 2021, 8:52 am by Lawrence B. Ebert
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]